Laurence Watts | Managing Director, Gilmartin Group LLC |
Talat Imran | CEO |
Svai Sanford | Chief Financial Officer |
Mir Hashim | Chief Scientific Officer |
Geoff Meacham | Bank of America |
Annabel Samimy | Stiefel |
Michelle Gilson | Canaccord Genuity |
Brandon Folkes | Cantor Fitzgerald |
Welcome to Rani Therapeutics Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are a in a listen-only mode.
Following management's prepared remarks, we'll hold a question-and-answer session. To ensure that we have ample time to adjust everyone's questions during the Q&A session, we'll ask for a limit of one question and one follow-up question per person. [Operator instructions] As a reminder, this call is being recorded today Tuesday, March 29, 2022.